Alnylam and Regeneron Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.